Prognostic Implications of Protein S-100β Serum Levels in the Clinical Outcome of High-Risk Melanoma Patients-Reference-Cited by-同舟云学术

Prognostic Implications of Protein S-100β Serum Levels in the Clinical Outcome of High-Risk Melanoma Patients

Published:2007 Issue:5 Volume:28 Page:264-272
ISSN:1423-0380
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol

Author:

Domingo-Domènech Josep,Castel Teresa,Auge Josep Maria,Garcia-Albeniz Xabier Adrian,Conill Carles,Puig Susana,Vilella Ramon,Matas Jose,Malvehy Josep,Gascón Pere,Mellado Begoña,Molina Rafael

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Reference30 articles.

1. A Pooled Analysis of Eastern Cooperative Oncology Group and Intergroup Trials of Adjuvant High-Dose Interferon for Melanoma

2. Does adjuvant interferon-α for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials

3. Interferon Alfa Therapy for Malignant Melanoma: A Systematic Review of Randomized Controlled Trials

4. An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.

5. Immunohistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against s-100 subunits

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Outcomes and Prognostic Factors of High-Risk Malignant Melanoma Patients after Surgery and Adjuvant High-Dose Interferon Treatment: A Single-Center Experience;Chemotherapy;2015-04-10

2. The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy;Medical Oncology;2014-12-14

3. Pattern of S100-release in benign and malignant diseases beside malignant melanoma/Freisetzung von S100 bei benignen und malignen Erkrankungen jenseits des malignen Melanoms;Laboratoriumsmedizin;2013-01-01

4. Protein and non-protein biomarkers in melanoma: a critical update;Amino Acids;2012-10-06

5. Determination of the biological variation of S100β and lactate dehydrogenase in disease-free patients with malignant melanoma;Clinical Chemistry and Laboratory Medicine;2012-05-01